Press Release: New Trend Report Confirms Drug Prices On Unsustainable Path
May 13, 2015
May 13, 2015 New Drug Report Reveals Drug Costs Top $50,000/year for Over Half… Read More
© 2025 CSRXP- All Rights Reserved
Updates
ICYMI: FDA Advisory Panel Approves New Cystic-Fibrosis Drug while Americans Continue to Pay the Price of High Cost Drugs
May 13, 2015
May 13, 2015 The New York Times: “Cystic Fibrosis Drug Wins Approval of… Read More
ICYMI: “As E&C Prepares Cures Bill Markup, Negative Press On Drug Prices On The Increase”
May 12, 2015
May 12, 2015 InsideHealthPolicy.com Health Reform Insider: “As E&C… Read More
ICYMI: Vertex’s Cystic-Fibrosis Drug Could Come at a Cost
May 11, 2015
May 11, 2015 The Wall Street Journal: “Vertex’s Cystic-Fibrosis… Read More
Weekly Update – How much is too much?
May 8, 2015
Weekly Update – 5/8/2015 We learned this week that worldwide spending on… Read More
ICYMI: Should the Specialty Drug Cost Debate Take a Breath? Data Proves Otherwise.
May 7, 2015
ICYMI: May 7, 2015 PharmaExec.com: “Take a Breath” on the Specialty Drug… Read More
ICYMI: Washington’s Role in High Drug Costs — Marketing Exclusivity and “Shadow Pricing”
May 6, 2015
ICYMI: May 6, 2015 National Journal: Washington’s Interest in Precision… Read More
ICYMI – Where’s Robert Stack When You Need Him?
May 5, 2015
ICYMI May 5, 2015 The New York Times: Runaway Drug Prices How companies set… Read More
ICYMI: High Drug Costs Impact Wall Street and Spark a New Initiative in the White House
Apr 28, 2015
April 28, 2015 Note: Distributing the New York Times article below is not an… Read More
ICYMI: Two WSJ Articles Highlight High Drug Prices
Apr 27, 2015
Two-fer ICYMI: Two WSJ Articles Highlight High Drug… Read More
National Coalition on Health Care highlights the impact of rising specialty drug prices
Apr 24, 2015
Originally published on AmericanPharmacyNews.com. Read More
Are Skyrocketing Drug Prices Really Needed for Innovation?
Apr 22, 2015
Are Skyrocketing Drug Prices Really Needed for Innovation? Amgen’s… Read More